Skip to content

LB&K: what changed

BE 0628.792.305NACE 72.101, Research and development on biotechnologyOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€31,397
2024 · €63,573-€32,176
Equity
€384,989
2024 · €353,592+€31,397
Cash
€296,799
2024 · €261,078+€35,721
Balance sheet total
€394,560
2024 · €362,551+€32,009

Largest movements

2024 to 2025
Assets
  • Cash +€35,721

    up €35,721 (+13.7%), from €261,078 to €296,799

    mainly Net result for the year (+€31,397) and Receivables within one year (+€5,002)

  • Receivables within one year -€5,002

    down €5,002 (-5.5%), from €91,502 to €86,500

    of which Other amounts receivable: -€17,248

Equity and liabilities
  • Profit (loss) carried forward +€31,397

    up €31,397 (+11.0%), from €284,992 to €316,389

Income statement
  • Gross operating margin -€40,782

    down €40,782 (-44.8%), from €91,110 to €50,328

  • Taxes -€10,019

    down €10,019 (-42.0%), from €23,879 to €13,860

  • Depreciation +€2,280

    up €2,280 (+201%), from €1,133 to €3,413

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €63,573
Gross operating margin -€40,782
Depreciation -€2,280
Other operating charges +€898
Financial charges -€32
Taxes +€10,019
Result 2025 €31,397
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€40,671
Investment -€4,950
Financing €0
Cash 2024 €261,078
Net result for the year +€31,397
Depreciation +€3,413
Receivables within one year +€5,002
Deferred charges and accrued income +€247
Trade debts +€612
Investment in fixed assets (net) -€4,950
Cash 2025 €296,799
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €362,551 €394,560 +€32,009 +8.8%
Fixed assets 21/28 €8,367 €9,904 +€1,537 +18.4%
Tangible fixed assets 22/27 €8,367 €9,904 +€1,537 +18.4%
Furniture and vehicles 24 €8,367 €9,904 +€1,537 +18.4%
Current assets 29/58 €354,185 €384,657 +€30,472 +8.6%
Amounts receivable within one year 40/41 €91,502 €86,500 -€5,002 -5.5%
Trade receivables 40 €58,976 €71,222 +€12,246 +20.8%
Other amounts receivable 41 €32,526 €15,278 -€17,248 -53.0%
Cash at bank and in hand 54/58 €261,078 €296,799 +€35,721 +13.7%
Deferred charges and accrued income 490/1 €1,604 €1,358 -€247 -15.4%
Total equity and liabilities 10/49 €362,551 €394,560 +€32,009 +8.8%
Equity 10/15 €353,592 €384,989 +€31,397 +8.9%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €50,000 €50,000 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €48,140 €48,140 = 0.0%
Profit (loss) carried forward 14 €284,992 €316,389 +€31,397 +11.0%
Amounts payable 17/49 €8,959 €9,571 +€612 +6.8%
Amounts payable within one year 42/48 €8,959 €9,571 +€612 +6.8%
Trade debts 44 €80 €692 +€612 +763%
Suppliers 440/4 €80 €692 +€612 +763%
Taxes, remuneration and social security 45 €8,879 €8,879 = 0.0%
Taxes 450/3 €8,879 €8,879 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,133 €3,413 +€2,280 +201%
Other operating charges 640/8 €2,361 €1,463 -€898 -38.0%
Gross operating margin 9900 €91,110 €50,328 -€40,782 -44.8%
Operating profit (loss) 9901 €87,616 €45,452 -€42,164 -48.1%
Financial charges 65/66B €163 €195 +€32 +19.6%
Recurring financial charges 65 €163 €195 +€32 +19.6%
Profit (loss) for the period before taxes 9903 €87,453 €45,257 -€42,196 -48.2%
Income taxes 67/77 €23,879 €13,860 -€10,019 -42.0%
Profit (loss) for the period 9904 €63,573 €31,397 -€32,176 -50.6%
Profit (loss) for the period to be appropriated 9905 €63,573 €31,397 -€32,176 -50.6%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€396,476 to €478,069

Midpoint €430,473 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €384,989
Capitalised earnings €407,964 to €571,150
Indication €396,476 to €478,069

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€384,989
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€384,989

Capitalised earnings

net result for the year (9904)
2025
€31,397
2024
€63,573
2023
€76,374
2022
€140,162
2021
€141,008
Average result
€57,115
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€407,964 / €475,958 / €571,150

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 16 November 2026 via checked.be.